Clinical trials
Lupus Erythematosus, Systemic trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2012 | 1 |
| 2015 | 2 |
| 2017 | 4 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 9 |
| 2023 | 9 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 36 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking Union Medical College Hospital | 3 |
| RenJi Hospital | 3 |
| The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 3 |
| Chinese SLE Treatment And Research Group | 2 |
| Nanfang Hospital, Southern Medical University | 2 |
| Peking University People's Hospital | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| Children's Hospital of Fudan University | 1 |
| Fen Li | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 36 |
| Lupus Nephritis | 4 |
| Scleroderma, Systemic | 4 |
| Autoimmune Diseases | 3 |
| Myositis | 3 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2 |
| Purpura, Thrombocytopenic, Idiopathic | 2 |
| Antiphospholipid Syndrome | 1 |
| Atherosclerosis | 1 |
| Connective Tissue Diseases | 1 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.